Appelhans Dannielle — SEC insider filings

SEC reporting owner CIK 1874962. 13 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2021-09-01 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Generation Bio Co. (GBIO)Director73 legs · 20,000 sh · $32,339—10
Rubius Therapeutics, Inc. (RUBY)CEO and President5—3 legs · 20,000 sh · $6,8828
HALOZYME THERAPEUTICS, INC. (HALO)Director1——2

Insider filings — Appelhans Dannielle

FiledFormIssuerReported transactionsSource
2026-09-024HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 1,161 @ $0 · Grant/award (A): 1,778 (derivative) @ $0EDGAR
2026-02-094Generation Bio Co. (GBIO)Code (U): 1,263 · Code (U): 736 · Disposition to issuer (D): 3,000 (derivative) · Disposition to issuer (D): 3,840 (derivative) · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 6,000 (derivative)EDGAR
2025-06-064Generation Bio Co. (GBIO)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-06-104Generation Bio Co. (GBIO)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2023-12-114Generation Bio Co. (GBIO)Purchase (P): 637 @ $1.82 · Purchase (P): 7,363 @ $1.79EDGAR
2023-12-064Generation Bio Co. (GBIO)Purchase (P): 12,000 @ $1.50EDGAR
2023-06-124Generation Bio Co. (GBIO)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-02-274Rubius Therapeutics, Inc. (RUBY)Sale (S): 10,385 @ $0.13EDGAR
2023-02-014Rubius Therapeutics, Inc. (RUBY)Option exercise (M): 7,500 · Sale (S): 3,878 @ $0.25 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2022-08-124Rubius Therapeutics, Inc. (RUBY)Option exercise (M): 12,500 · Sale (S): 5,737 @ $0.80 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2022-07-194Generation Bio Co. (GBIO)Grant/award (A): 38,400 (derivative) @ $0EDGAR
2022-02-014Rubius Therapeutics, Inc. (RUBY)Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-09-014Rubius Therapeutics, Inc. (RUBY)Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1874962 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs